Sunesis Pharmaceuticals (SNSS) Posts Mixed Q4 Results
Tweet
Share
E-mailGet Alerts SNSS Hot Sheet
Price: $5.32 --0%
Financial Fact:
Loss from operations: -9.99M
Today's EPS Names:
SFST, VLTO, CLIR, More
Financial Fact:
Loss from operations: -9.99M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Sunesis Pharmaceuticals (NASDAQ: SNSS) reported Q4 EPS of ($0.02), $0.17 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $896 thousand versus the consensus estimate of $1.17 million.
For earnings history and earnings-related data on Sunesis Pharmaceuticals (SNSS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- Steel Dynamics (STLD) Tops Q1 EPS by 16c
- Eastgroup Properties (EGP) Tops Q1 EPS by 17c, provides guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
